Get the Daily Brief
Latest Biotech News
Cutting-edge AI and bioinformatics tools target undruggable proteins and tumor microenvironment
Innovative computational and AI-driven methods are unlocking novel drug discovery pathways. David Baker's lab has engineered AI approaches to design binders targeting intrinsically disordered...
Regulatory and reimbursement challenges impact diagnostic and therapeutic sectors
The FDA and Medicare continue to influence diagnostic test coverage and therapy approvals, shaping market dynamics. Proposed local coverage determinations by Medicare contractor MolDx for...
Notable clinical trial and drug development updates across diverse indications
Recent clinical developments span multiple bioscience areas. Novo Nordisk is preparing Phase 3 trials for an amylin analog and GLP-1 agonist combo targeting weight loss. Diamedica has reported...
Major corporate movements in biotech and med-tech sectors
Strategic leadership changes and corporate consolidations are underway. Novartis named a new CFO, Pranav Mehta, to steer financial strategy amid evolving company goals. Waters Corporation...
Emerging research and technology in neuroscience, immunology, and molecular biology
Cutting-edge studies and innovations shed light on complex biological processes and disease mechanisms. Research explores brain endothelial gap junctions enabling rapid blood flow during neural...
Sarepta’s Gene Therapy Safety Concerns and Major Restructuring
Sarepta Therapeutics faces mounting challenges following the deaths of three patients linked to its gene therapies, notably the Duchenne muscular dystrophy treatment Elevidys and an...
Advances in Three-Person IVF Technology and Mitochondrial Disease Prevention
Recent reports confirm the birth of eight healthy babies in the UK through three-person IVF techniques that replace mitochondrial DNA to prevent transmission of mitochondrial diseases. This...
FDA Advisory Committee Rejects GSK’s Blenrep for Multiple Myeloma
The FDA’s Oncologic Drugs Advisory Committee voted against the approval of GSK’s antibody-drug conjugate Blenrep (belantamab mafodotin) for relapsed/refractory multiple myeloma in combination...
Bristol Myers Squibb’s Reblozyl Fails Phase III Myelofibrosis Anemia Trial
Bristol Myers Squibb's anemia drug Reblozyl missed the primary endpoint in the Phase III INDEPENDENCE trial for myelofibrosis-associated anemia, failing to achieve sustained transfusion...
Life Sciences Venture Financing Trends and Market Analysis
Life sciences sector financing experienced a slowdown in the first half of 2025, with total venture funding decreasing to $12.7 billion from $16.9 billion in 2024, as reported by BioCentury....
Regulatory and Strategic Shifts in Pharma Due to US Tariff Threats and Policies
Pharmaceutical companies are bracing for the impact of potential U.S. drug tariffs anticipated by the end of July under the Trump administration. Despite the uncertainty, Johnson & Johnson CEO...
Innovations in AI for Protein Design and Undruggable Targets
David Baker’s lab at the University of Washington has unveiled AI-driven approaches to design binders targeting intrinsically disordered regions (IDRs) of proteins, overcoming long-standing...
Spatial and Single-Cell Biology Projects Aim to Advance Cancer Drug Discovery
Collaborations involving the A*STAR Genome Institute of Singapore and 10x Genomics are launching large-scale spatial transcriptomics studies analyzing up to 2,500 patient tissue samples across...
Abbott, Johnson & Johnson Report Mixed Diagnostics and MedTech Earnings Amid Market Pressures
Abbott Laboratories reported a 1% dip in second quarter diagnostics revenue to $2.17 billion, pressured by falling COVID-19 test sales and China's volume-based procurement impact. Notably, core...
Emerging Therapeutics and Diagnostics: AI, Gene Editing, and Rare Diseases
Biotech innovations highlight a diverse array of advancements: Theranostic efforts using AI-powered tumor microenvironment deconvolution tools, gene editing therapies for cystic fibrosis supported...
Sarepta Therapeutics Reorganizes Amid Safety Warnings and Deaths
Sarepta Therapeutics has enacted a major restructuring following safety concerns related to its Duchenne muscular dystrophy gene therapy Elevidys. The company is cutting approximately 36% of its...
Breakthroughs in Three-Person IVF and Mitochondrial Disease Prevention
Researchers in the UK have reported the successful birth of eight healthy babies conceived using mitochondrial donation and pronuclear transfer techniques to prevent mitochondrial DNA disease...
Johnson & Johnson Posts Record Drug Sales Amid Stelara Patent Cliff
Johnson & Johnson reported a record-breaking quarter exceeding $15 billion in pharmaceutical sales, despite significant declines in its blockbuster drug Stelara due to generic competition. The...
FDA and Industry Debates Surround COVID-19 Vaccine Use and Gene Therapy Approvals
The FDA’s regulatory decisions have highlighted internal disagreements, especially regarding COVID-19 vaccines for children and gene therapy approvals. Center for Biologics Evaluation and Research...
AI and Molecular Innovations Propel Drug Discovery and Diagnostics
Advances leveraging artificial intelligence (AI) are reshaping drug discovery, diagnostics, and biomanufacturing. The Baker lab announced AI techniques to drug intrinsically disordered proteins...